About the Gavi CSO funding mechanism

Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate more than half the world's children against some of the world’s deadliest diseases. To help increase immunisation coverage in lower-income countries, Gavi is launching a series of opportunities for civil society organisations (CSOs) to apply for funding directly from Gavi. These include country-specific calls for proposals, alongside single-source funding driven by countries and approved by governments. This approach reflects a wider commitment from governments to endorse the role of CSOs in extending immunisation services to reach all communities.

There are three clear aims of the CSO funding mechanism.

  1. to increase immunisation coverage and reduce the number of zero-dose and under-immunised children;
  2. to support the roll-out of HPV vaccines to increase coverage; and
  3. to support the roll-out of COVID-19 vaccines as an integral part of routine immunisation to increase both COVID-19 and routine immunisation coverage.

This funding mechanism will support Gavi to engage and work with a diverse range of CSOs and reach even more communities in Gavi eligible countries.

How will this work?

Gavi is supported by MannionDaniels, a global health and social development consultancy, which is working with Oxford Policy Management (OPM) in a consortium, to design calls for proposals receive applications, and manage grants to national and local CSOs to implement vaccination projects focused on increasing demand generation, community engagement, and service delivery. Their extensive experience as fund managers will ensure every step of the grant management process is considered: from application, due diligence, pre-award review, contracting and initial disbursement, to project delivery and learning, monitoring and reporting. Successful grantees will be supported every step of the way.

Opportunities for funding are tailored to country requirements

No one solution is appropriate for every Gavi-eligible country; therefore, opportunities for funding are unique and distinct. The CSO funding mechanism is tailored to the individual country’s requirements, so applicants for each opportunity should read the criteria carefully. All decisions relating to grant opportunities are made in close consultation with the Ministries of Health and stakeholders within the relevant Gavi-supported country. Further information is available in the Application guidance page when a funding opportunity is available.

Where this is an open call for proposals, it will be highlighted on the Application guidance page. All applications should only be completed on Grantelope, the online grant management system.

Contact us

If an applicant has concerns or questions relating to their proposal, they should submit a query to the support enquiry mailbox: gavi-cso@manniondaniels.com

Alternatively, raise a query directly on Grantelope, the online grants management system, where all applications will be completed and submitted.


Latest news

Nearly 200 million vaccine doses allocated to reach millions of children missed during COVID-19 pandemic

The allocation follows a Gavi Board decision in December 2023 to approve US$ 290 million funding for the “Big Catch-Up” initiative.

Gavi and Côte d'Ivoire commit to a successful programmatic and financial transition

Côte d’Ivoire commits to fully finance its routine immunisation programme over the next five years to ensure sustainability beyond Gavi support.

South Sudan Launches R21 Malaria Vaccine Rollout to Protect Children

In a historic move to combat the devastating impact of malaria, the Ministry of Health, in partnership with UNICEF and the World Health Organization and Gavi, The Vaccine Alliance, today launched the nationwide rollout of the R21 malaria vaccine…

Gavi receives top marks for aid transparency fifth year in a row

Gavi, the Vaccine Alliance, has been ranked in the ‘Very good’ category for the fifth time in the 2024 Publish What You Fund (PWYF) Index, a leading assessment of aid transparency.

Protecting more children, against more diseases, faster than ever before: Gavi, the Vaccine Alliance unveils plans for next 5-year period

Gavi’s new Investment Opportunity outlines plans for the Vaccine Alliance to protect 500 million children, saving over 8 million lives between 2026 and 2030.

Gavi to boost access to life-saving human rabies vaccines in over 50 countries

Gavi, the Vaccine Alliance, in collaboration with partners, has announced support for human rabies vaccines for post exposure prophylaxis (PEP) as part of routine immunisation.

Gavi announces launch of preventive Ebola, routine multivalent meningitis, human rabies, and hepatitis B birth dose vaccination programmes

Gavi, the Vaccine Alliance today announced that the lower-income countries it supports can now apply to introduce four additional vaccines: preventive Ebola, human rabies vaccine for post-exposure prophylaxis, multivalent meningococcal…

Last updated: 4 Jul 2024

Subscribe to our newsletter